JIMMIE'S LAW
Promoting Medication Safety & Patient Protection
Inspired by Jimmie Wilson's Story
What is Jimmie's Law?
One moment changed everything - after surviving drug-induced liver injury, Jimmie now works to advance legislation to prevent similar, avoidable harm.
Jimmie’s Law is The JADA Foundation’s public safety initiative dedicated to strengthening medication safety, pharmacy accountability, and patient protection through education and responsible legislative engagement
The Need for Action
As of September 9, 2025, the FDA’s Adverse Event Reporting System had logged about 1,424 adverse-event reports associated with compounded GLP-1 drugs in the U.S., including 329 hospitalizations and 23 deaths. These figures represent the total reported to the FDA over the reporting period, not necessarily new annual cases, and likely underestimate the actual number, since many compounding pharmacies are not required to report adverse events.
Compounded Semaglutide
605 adverse event reports associated with compounded semaglutide
Compounded Trizepatide
545 adverse event reports associated with compounded tirzepatide
Compounded
GLP-1
Total: 1,150 adverse event reports with compounded GLP-1.
Featured Legislation
HB 729 - Pharmaceutical Drug Safety
HB 729 strengthens Kentucky pharmaceutical drug safety by expanding Board of Pharmacy oversight, requiring permits for terminal distributors, enhancing inspection authority, mandating adverse event reporting, regulating compounding standards, restricting improper drug sourcing, and increasing enforcement tools to protect public health and patient safety.
The JADA Foundation supports HB 729 as a meaningful step toward strengthening pharmaceutical oversight, enhancing compounding and distribution safeguards, and improving adverse event reporting to better protect patients and promote medication safety across the Commonwealth.
Representative Vanessa Grossl, Republican, District 88, officially files the regular session 2026, House Bill 729.
House Standing Committee
Licensing, Occupations, & Administrative Regulations (H) - NO ACTION!
HB 729 was assigned by the House Speaker to the committee on March 4, 2026. Committee Chairperson Representative Matthew Koch failed to schedule the bill for a committee hearing.
NOT ENACTED
Kentucky Legislative Session 2027 Initiative
The JADA Foundation will refocus its support for Jimmie's Law legislative efforts to reintroduce the bill in the Kentucky House and Senate for Regular Session 2027. Click below to review the proposed updates and revisions designed to ensure public health and patient safety.
DISCLAIMER
The JADA Foundation provides educational information regarding proposed patient safety legislation. The Foundation does not endorse political candidates and engages in advocacy consistent with federal 501(c)(3) guidelines.
